Mouse Anti-CUZD1 Recombinant Antibody (CBXC-3145) (V2LY-0125-LY557)

Mapes, J., Anandan, L., Li, Q., Neff, A., Clevenger, C. V., Bagchi, I. C., & Bagchi, M. K. (2018). Aberrantly high expression of the CUB and zona pellucida-like domain-containing protein 1 (CUZD1) in mammary epithelium leads to breast tumorigenesis. Journal of Biological Chemistry, 293(8), 2850-2864.

Farkona, S., Soosaipillai, A., Filippou, P., Liaskos, C., Bogdanos, D. P., Diamandis, E. P., & Blasutig, I. M. (2017). Novel immunoassays for detection of CUZD1 autoantibodies in serum of patients with inflammatory bowel diseases. Clinical Chemistry and Laboratory Medicine (CCLM), 55(10), 1574-1581.

Mapes, J., Li, Q., Kannan, A., Anandan, L., Laws, M., Lydon, J. P., ... & Bagchi, M. K. (2017). CUZD1 is a critical mediator of the JAK/STAT5 signaling pathway that controls mammary gland development during pregnancy. PLoS genetics, 13(3), e1006654.

Farkona, S., Soosaipillai, A., Filippou, P., Korbakis, D., Serra, S., Rückert, F., ... & Blasutig, I. M. (2017). Generation of monoclonal antibodies and development of an immunofluorometric assay for the detection of CUZD1 in tissues and biological fluids. Clinical Biochemistry, 50(18), 1168-1174.

Mapes, J. E. (2017). Investigation of the role of CUZD1-STAT5 signaling in mammary gland development and breast cancer (Doctoral dissertation, University of Illinois at Urbana-Champaign).

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols